Financials in USD. Standardized financial statements.
A compact view of how TransMedics Group, Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $605.49M | $441.54M | $241.62M | $93.46M | $30.26M | $25.64M | $23.60M | $13.02M | $7.68M | $6.21M |
| Revenue Growth? | +37.1% | +82.7% | +158.5% | +208.8% | +18.0% | +8.6% | +81.3% | +69.4% | +23.8% | 0.0% |
| Cost of Revenue? | $242.69M | $179.46M | $87.53M | $28.19M | $9.10M | $9.00M | $9.74M | $7.28M | $5.55M | $5.44M |
| Gross Profit? | $362.81M | $262.08M | $154.09M | $65.27M | $21.16M | $16.64M | $13.86M | $5.73M | $2.14M | $766,000 |
| Gross Margin? | +59.9% | +59.4% | +63.8% | +69.8% | +69.9% | +64.9% | +58.7% | +44.1% | +27.8% | +12.3% |
| Operating Expenses? | $254.22M | $224.59M | $182.82M | $96.71M | $60.59M | $43.02M | $43.47M | $25.97M | $22.56M | $23.75M |
| Operating Income? | $108.58M | $37.50M | -$28.73M | -$31.44M | -$39.43M | -$26.38M | -$29.60M | -$20.24M | -$20.43M | -$22.99M |
| EBITDA? | $148.49M | $69.95M | -$7.70M | -$28.96M | -$38.49M | -$23.15M | -$27.93M | -$20.23M | -$19.09M | -$22.66M |
| Income Before Tax | $107.52M | $35.78M | -$26.67M | -$36.16M | -$44.18M | -$28.72M | -$33.51M | -$23.71M | -$20.79M | -$24.07M |
| Income Tax Expense | -$82.77M | $316,000 | -$1.64M | $66,000 | $36,000 | $32,000 | $40,000 | $41,000 | $32,000 | $0 |
| Net Income? | $190.29M | $35.46M | -$25.03M | -$36.23M | -$44.22M | -$28.75M | -$33.55M | -$23.76M | -$20.82M | -$24.07M |
| EPS? | $5.60 | $1.07 | $-0.77 | $-1.23 | $-1.60 | $-1.16 | $-2.36 | $-1.23 | $-1.44 | $-1.66 |
| Diluted EPS? | $4.87 | $1.01 | $-0.77 | $-1.23 | $-1.60 | $-1.16 | $-2.36 | $-1.23 | $-1.44 | $-1.66 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality